A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer.
about
Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer MetabolismLong non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasisLong Non-coding RNAs in Urologic Malignancies: Functional Roles and Clinical TranslationCirculating Long Noncoding RNA as a Potential Target for Prostate CancerRNA biomarkers to facilitate the identification of aggressive prostate cancerLong noncoding RNAs in cancer: from function to translation.MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner.Long noncoding RNAs in prostate cancer: overview and clinical implications.Concurrent nuclear ERG and MYC protein overexpression defines a subset of locally advanced prostate cancer: Potential opportunities for synergistic targeted therapeutics.Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer.Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancerThe ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer.Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?Screening for Prostate Cancer-Beyond Total PSA, Utilization of Novel Biomarkers.From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis.Inhibiting malignant phenotypes of the bladder cancer cells by silencing long noncoding RNA SChLAP1.Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo.The bright side of dark matter: lncRNAs in cancerCurrent Insights into Long Non-Coding RNAs (LncRNAs) in Prostate CancerOverexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate Cancer.The prognostic value of long noncoding RNAs in prostate cancer: a systematic review and meta-analysis.Long non-coding RNAs and prostate cancer.Simultaneous Detection of Protein and mRNA in Jurkat and KG-1a Cells by Mass Cytometry.Long Non-coding RNAs in Prostate Cancer with Emphasis on Second Chromosome Locus Associated with Prostate-1 Expression.Long Non-coding RNA Linc-ROR Is Upregulated in Papillary Thyroid Carcinoma.Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA.Long non-coding RNA GAS5 and ZFAS1 are prognostic markers involved in translation targeted by miR-940 in prostate cancer.The prognostic value of abnormally expressed lncRNAs in prostatic carcinoma: A systematic review and meta-analysis.Regulatory role of long non-coding RNAs during reproductive disease.LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals.Increased expression of long non-coding RNA GLIDR in prostate cancer.The use of long non-coding RNAs as prognostic biomarkers and therapeutic targets in prostate cancer.Molecular correlates of intermediate- and high-risk localized prostate cancerPathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding starCarcinogenesis in prostate cancer: The role of long non-coding RNAsRole of exosomal small RNA in prostate cancer metastasis
P2860
Q26774456-B5A035A6-25FB-4F1C-B0A9-F28BDFB176D7Q28069105-F4EE47C5-FAC6-4878-A75E-F17D0E08371FQ28071872-E1A08020-7160-4E90-B84B-357E4F559164Q35814012-265FC7BE-920C-4B05-8B46-882A1E6B4A6DQ36260364-0B45A691-2599-4061-8B82-A5A563CB114FQ36353705-2D79F64D-1D75-42D4-BEE2-618473C0B09DQ36823926-298944D8-BA5E-404B-936D-13C631792C4EQ37113177-E1590581-1D3F-468A-953C-F51A31D8AA8EQ37156611-D68BE37E-E862-422E-AD76-544384D1077DQ37246050-53CD5B83-5425-4C54-BB9F-334B1EDA1F27Q37645051-9CF0B038-A955-46C9-8A4D-562DE259D50CQ37662159-A2E2B6AD-3761-44E9-A479-FF536679DD61Q37724539-E63C2AD7-F702-4657-93DE-799C89A63F58Q38546301-C90F7EDD-A07E-4C1B-9E72-432F1F8724F0Q38732993-F9838B3F-9EC5-452D-9869-FC3885A598F2Q38795378-3E696822-04D3-4CB3-ACB7-AC32EF384648Q38800573-B58E50FB-4D15-4F88-8267-7D8F44184FB2Q38903008-9539D314-F8F1-45D8-A16D-5A1735FD0B23Q38915010-850F698A-0971-4492-B7C4-4615C6998050Q39152842-E45A2465-C7F0-4CBB-96F7-6D3504FC0912Q41004851-BBB0A755-9569-483D-A48F-F25152539C2CQ41339824-9D6C2046-42FB-43D2-90E2-68BDB955FE17Q43061701-5E5FA7C2-9C8E-40DA-A180-D8A9E687CD2FQ46721245-CC42A5D6-544A-4592-8AEB-AA33B113473AQ47193237-878680B1-7F33-4797-903A-C3DABCCAB401Q47252793-853BE180-09A1-4378-923F-AD22AC7C1B84Q47289701-68587C26-50A0-42D9-995B-F1FF1D9123A8Q49213554-80158722-79FF-47B4-8B5C-DBF1FE4B4474Q49486523-17361199-4561-4A67-ACC9-1D8807A57CA2Q49569163-7A84F955-3B13-4509-9385-08FD3421A78AQ50927478-D8F3E4B1-2E03-4806-9501-0F0D47C498E0Q50999956-EDF81B27-A950-4E0E-A7B5-C4D36BC17FC8Q55356724-AD3AF39F-941C-4794-A33E-3691C3A2E292Q57109051-A9A7E8DB-E0CC-46E3-8C44-6BCB6A6397BFQ57109348-0DBAC94A-AE64-44A6-B8CB-FAB91E2B7619Q57114753-05BFFB6B-AF45-4DCE-B5CC-51BB2A0A63A3Q57489975-02292AF2-FDF6-4914-A0FA-735B22C2C259
P2860
A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A novel RNA in situ hybridizat ...... lly localized prostate cancer.
@ast
A novel RNA in situ hybridizat ...... lly localized prostate cancer.
@en
type
label
A novel RNA in situ hybridizat ...... lly localized prostate cancer.
@ast
A novel RNA in situ hybridizat ...... lly localized prostate cancer.
@en
prefLabel
A novel RNA in situ hybridizat ...... lly localized prostate cancer.
@ast
A novel RNA in situ hybridizat ...... lly localized prostate cancer.
@en
P2093
P2860
P1433
P1476
A novel RNA in situ hybridizat ...... lly localized prostate cancer.
@en
P2093
Aaron M Udager
Anirban Sahu
Arul M Chinnaiyan
Felix Y Feng
Javed Siddiqui
Matthew K Iyer
Rohit Mehra
Xuhong Cao
P2860
P304
P356
10.1016/J.NEO.2014.11.006
P577
2014-12-01T00:00:00Z